Skip to content

Pacira BioSciences, Inc. Price, Chart & Factor Analysis

Free Data & Analytics Access

Latest earnings: November 9, 2026 results vs estimates

Pacira BioSciences, Inc. · E.PCRX.NASDAQ · United States
Use symbol E.PCRX.NASDAQ in our API & Excel add-in to retrieve this data ↓
36.39
(+0.00%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 100%
Trend 100%
Bubble Risk LOW
Realised Volatility (20D) 157.72%

Pacira BioSciences, Inc. Forecast

Pacira BioSciences, Inc. short-term momentum is strongly positive (up over 4 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (8 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 157.7% a year, a typical one-standard-deviation range is 28.31–44.47 over a week, 19.82–52.96 over a month and -21.00–93.78 over a year. (Signals as of 1 Nov 2026.)

Pacira BioSciences, Inc. Price Chart

MacroFinance.ai

Pacira BioSciences, Inc. Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Pacira BioSciences, Inc.
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Pacira BioSciences, Inc.
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Pacira BioSciences, Inc.
Signal
0
ⓘLatest reading of Signal.
Teal = supportive for Pacira BioSciences, Inc., red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Research on Pacira BioSciences, Inc.

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Pacira BioSciences, Inc. Trading Strategies

58 backtested tactical asset allocation strategies hold SPY (US market) or XLV (Health Care sector), the closest tradable exposure to Pacira BioSciences, Inc.; 28 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

From creators

See all 58 strategies holding SPY, XLV →

Statistical Distribution of Returns

Plus

How Pacira BioSciences, Inc.’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Pacira BioSciences, Inc. behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Pacira BioSciences, Inc. (United States)

Pacira BioSciences, Inc. is a listed security in the United States. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

Frequently asked questions

What is Pacira BioSciences, Inc.?
Pacira BioSciences, Inc. is a listed security in the United States. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Pacira BioSciences, Inc. price?
The latest close is 36.39 (1 Nov 2026), +0.00% on the day. The price at the top of the page refreshes during the trading day.
Is Pacira BioSciences, Inc. in an uptrend?
As of 1 Nov 2026, short-term momentum is strongly positive (4 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly positive (8 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Pacira BioSciences, Inc.?
20-day realised volatility is 157.7% a year (1 Nov 2026), which implies a typical one-standard-deviation move of about 45.5% over a month and 22.2% over a week.
What factors affect Pacira BioSciences, Inc.?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Pacira BioSciences, Inc., grouped as Quantitative Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Pacira BioSciences, Inc.?
58 backtested tactical asset allocation strategies trade Pacira BioSciences, Inc. through SPY, XLV; 28 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Pacira BioSciences, Inc. returns analysed?
The Statistical Distribution of Returns section shows the distribution of Pacira BioSciences, Inc. daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Pacira BioSciences, Inc. historical data?
In the Free historical data section of this page: the last 10 years of Pacira BioSciences, Inc. daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Pacira BioSciences, Inc. historical data (last 10 years)

Browse or instantly download the last 10 years of Pacira BioSciences, Inc. daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.PCRX.NASDAQ&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-200.405
2026-11-190.405
2026-11-180.4
2026-11-170.41
2026-11-160.4
2026-11-130.41
2026-11-120.41
2026-11-1136.46
2026-11-1036.49
2026-11-0936.46
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.